💡West Africa is one step closer to being protected against the deadly Lassa fever disease with IAVI's vaccine candidate, supported by CEPI, showing promise in the first stage of clinical testing. Results from the Phase I trial are published in @nejm.org.

Last week, Cepheid announced that its Xpert MTB/XDR test for TB drug resistance has been prequalified by WHO, enabling procurement through international agencies and greater access in areas with a high TB burden. www.ghtcoalition.org/blog/researc...

GHTC welcomes the strong R&D language in South Africa's draft #G20 health ministerial declaration and urges health ministers to strengthen the final text with concrete measures to drive tangible action. www.ghtcoalition.org/news/ghtc-we...

Researchers have developed an antivenom using antibodies from a llama and an alpaca that can neutralize venom from some of the deadliest snakes. Snakebites are a neglected public health issue that kill around 20,000 people in sub-Saharan Africa yearly. www.ghtcoalition.org/blog/researc...

Symposium: MMV & partners at #ASTMH2025 📅 10 Nov: Evidence to guide the implementation of effective P. vivax radical cure Lessons from Brazil, Peru, PNG & Indonesia on optimizing radical cure for vivax #malaria relapse prevention Speakers & topics 👉 bit.ly/3KVqVx7

So close to the Nov 9 kick-off of #TropMed25 in Toronto! Here's our Annual Meeting blog preview: tinyurl.com/mer4yd26

Broadly protective coronavirus vaccines could offer an alternative to the ‘one bug, one drug' approach. We spoke to Dr Michael Osterholm, Director of CIDRAP, about a new CEPI-funded initiative mapping out research into all-in-one coronavirus vaccines ⬇️ cepi.net/big-one-comi...

🎉 We are pleased to share that the @ec.europa.eu will invest €20M to develop urgently needed dengue medicines in partnership with @afd-france.bsky.social and DNDi. Dengue is a fast-spreading, climate-sensitive disease for which there is still no specific treatment. 🔗 bit.ly/437AJdO

Researchers have identified a promising antibiotic that seems to be much more effective than existing drugs against deadly superbugs, encouraging news as the global threat of #AMR continues to grow and the pipeline of antibiotics continues to fall short. t.co/DNOvYmfk8h

What's new in #GlobalHealth R&D? 🔬Potent antibiotic discovery 🐍Broad-spectrum antivenom 🧪Prequalified TB test www.ghtcoalition.org/blog/researc...

The field of #GlobalHealth research is awash in alphabet soup. 🔤 🥣 But GHTC is here to help you digest it all with our R&D dictionary. 🌍🔬🕮 👉🏽 Check it out! www.ghtcoalition.org/global-healt...

A research team presented new data last week, showing that cancer patients who received COVID-19 mRNA vaccines within 100 days of starting immunotherapy drugs survived more often than non-vaccinated patients. www.ghtcoalition.org/blog/researc...

From a next-gen #polio vaccine to a groundbreaking #AIForHealth clinical trial, PATH teams made incredible progress last year. In fact, we reached 66 people every *minute* with the health care they need to thrive. Explore our 2024 Annual Report: https://bit.ly/4hCELAM

Malaria can become deadly within hours. Through SEMA ReACT, MMV & partners are studying rectal artesunate use in remote Zambia & DRC to improve severe #malaria care. Join us at #ASTMH2025 (11 Nov) for a symposium sharing interim results & insights 👉 bit.ly/46Z7ADQ

🌎 How do infectious diseases shape our response to climate change? Register now for the free, online SBI Scientific Symposium Nov. 1, 7:30–11am ET: “From Local to Global: The Role of Infectious Diseases in Responding to Climate Change.” www.sympla.com.br/evento-onlin...

US support advanced 67 new technologies approved since 1999 for neglected & (non-COVID) emerging infectious diseases + 261 promising innovations in late-stage development. Explore the full return on America’s #GlobalHealth R&D investments. #Innovate4Health www.ghtcoalition.org/resources-it...

Last week, California-based True Diagnostics announced that it had received an award of upward of $11 million from BARDA to support the development of a blood-based rapid antigen test for #Ebola and #Marburg viruses. www.ghtcoalition.org/blog/researc...

GHTC and members were on Capitol Hill today to make the case for maintaining and strengthening #GlobalHealth R&D funding and programming across the US government, pointing to the immense health, economic, and security benefits for America and the world.

On November 12, the O'Neill Institute at Georgetown Law will host "Innovative HIV Prevention and Treatment," an in-depth discussion on Lenacapavir. Register here: ow.ly/Xgpy50XiW3O @oneillinstitute.bsky.social #LEN #HIV

A systematic review and meta-analysis of studies looking at the effectiveness of typhoid conjugate vaccines found that they are highly effective in preventing typhoid fever in countries where the infection is endemic. www.ghtcoalition.org/blog/researc...

What's new in #GlobalHealth R&D? 💉Typhoid conjugate vaccine study 🩸Ebola/Marburg test funding 🥼COVID mRNA vaccines help cancer patients www.ghtcoalition.org/blog/researc...

To #EndtheNeglect on #NTDs, we must keep innovating in science, systems, and partnerships. Join us for an engaging conversation on the sidelines of #CPHIA2025 AfricaCDC 🗓️24 October, 2025 ⏲️16:00 -17:30 SAST 📍Meeting Room 12CD, Durban ICC

In Durban for #CPHIA2025? Join PATH and @impactglobalhealth.bsky.social on Saturday for this side event on health financing in Africa, moderated by our own @berniearyeetey.bsky.social 👇

A research team from the German University of Würzburg has developed a method for diagnosing viral infections that leverages the unique features of the human tongue, which could be incorporated into gum or a lollipop. www.ghtcoalition.org/blog/researc...

#GlobalHealth innovation is good for the world, good for America, and good for each state in the US. Learn more! www.ghtcoalition.org/across-the-us

New CEPI-funded project will harness innovative microbial testing methods to accelerate vaccine sterility testing from weeks to days. CEPI funding of up to US$197,280 will support Swedish-based Symcel to develop a rapid sterility testing method for vaccines using its calScreener+ platform.

@cepi.net is partnering with the Serum Institute of India, the largest vaccine manufacturer in the world, to develop a new vaccine targeting H5N1 avian flu that elicits a broad immune response across multiple H5 viral strains. www.ghtcoalition.org/blog/researc...

Join CARB-X Chief Scientific Officer Richard Alm, PhD, at the @latrobeuni.bsky.social Frontiers in Infectious Diseases Innovation event for his presentation “CARB-X – Accelerating the Development of Novel Products to Tackle AMR.” #IDSky 🧪 📆 October 29 ⏰ 5 – 7 PM AEDT 🔗 Register: bit.ly/3IOo9Jy

New tools for detection & treatment of #PVivax malaria are expanding access to radical cure treatment options—but turning innovation into impact requires more than approval. Join the #PATHLiveForum on 10/29 👉 bit.ly/46SoEvb @oficialfiocruz.bsky.social @menziesresearch.bsky.social @who.int @mmv.org

Last week, Monod Bio announced that it has received a $750,000 grant from the @gatesfoundation.bsky.social Grand Challenges initiative to develop a point-of-care test for preeclampsia, which is a leading cause of maternal deaths. www.ghtcoalition.org/blog/researc...

What's new in #GlobalHealth R&D? 🧪Preeclampsia test funding 💉Partnership on flu vaccine development 👅Chewing gum flu testing method www.ghtcoalition.org/blog/researc...

#DYK: Over 1 billion people globally are affected by neglected diseases. There remains an urgent need for new technologies to fight longstanding and emerging threats. #GlobalHealth 👇🏼 www.ghtcoalition.org/why-research...

Join Oct 24th 12PM ET for a conversation with @jennifernuzzo.bsky.social & @drsethberkley.bsky.social where they will discuss the current landscape of global health, the ongoing fight for vaccine equity and his forthcoming book #FairDoses. Register here ⤵️ brown.zoom.us/webinar/regi...

⏳ One month to go! Submit your abstract for ACC 2026 and join researchers worldwide shaping the future of #AMR. Topics can include child and maternal health, diagnostics, stewardship, innovation, AI and more. Deadline: 14 Nov 2025, 17:00 GMT 🔗 acc-conference.com#posters

Last week, SAFIRE consortium announced that it had enrolled its first patient in Mali, marking the start of the first-ever Phase 3 adaptive platform trial evaluating the efficacy and safety of antimalarial drugs in the first trimester of pregnancy. #malaria www.ghtcoalition.org/blog/researc...

📑 Drug-resistant infections have reached a tipping point. Without urgent action, #AMR deaths could rise by 70% by 2050. We need innovation and access to the right antibiotics. 🌍 🔗Read Dr Manica Balasegaram’s @theguardian.com piece: www.theguardian.com/global-devel...

MMV has joined the @who.int Global Clinical Trials Forum – a major step towards more inclusive #malaria research that reflects the people treatments are meant to serve. Learn more 🔗 bit.ly/47myHc6

Are we focusing on the most critical levers to end #malaria? Join MMV & @gatesfoundation.bsky.social at #ASTMH2025 to explore how breakthrough tools, smart strategies and endemic country leadership can help end malaria in our lifetime. 📅 Nov 12, 7:00am bit.ly/4356K60

Per Dr. Shabir Madhi, Africa is "a success story over the past decade in vaccine uptake." Learn how African governments can capitalize on this research on the next Getting to Zero episode with host Dr. Nginache Nampota-Nkomba. October 23 at 12 p.m. ET 🎥: https://www.youtube.com/watch?v=pvY6bS_JtoE

As we saw with #COVID19, an outbreak anywhere could quickly become a devastating pandemic. New #vaccines, #drugs, #diagnostics, and other tools are urgently needed to #OutsmartEpidemics. Learn more about technologies on the horizon💉💊🔬 www.ghtcoalition.org/rd-across-he...

Following the example of the US military, who often wear uniforms treated with insecticide to repel mosquitoes in malaria-endemic regions, a research team has tested a similar approach to try to protect young children, who face a significant burden of #malaria. www.ghtcoalition.org/blog/researc...

A research team shared the results of the Phase 1 trial of a novel vaccine designed to protect against typhoid fever and non-typhoidal Salmonella infections, reporting that the vaccine produced a strong immune response and was safe and well-tolerated. www.ghtcoalition.org/blog/researc...

Ending #malaria could save millions – and generate trillions. A new Malaria No More and Corporate Council on Africa report shows that ending malaria is not just a humanitarian goal, but one of the world’s largest untapped business opportunities: bit.ly/43222pA

What's new in #GlobalHealth R&D? 💉Vaccine for Salmonella/typhoid 🦟Insecticide-treated baby wraps for #malaria prevention 💊Malaria drug trial in pregnant women www.ghtcoalition.org/blog/researc...

GHTC’s Executive Director Kristie Mikus spoke at #WHS2025 yesterday on Malaria & Global Health Security. Tackling #malaria strengthens health systems, drives collaboration, and accelerates progress against infectious diseases worldwide. Thank you to our partners for a great discussion! @mmv.org

What are the steps needed to move a #GlobalHealth product from idea 💡 to impact 👩🏾‍⚕️ 💉? Find out in our Pipeline of Promise infographic ⬇️ www.ghtcoalition.org/pipeline-of-...

Recent NIH funding cuts & policy shifts could jeopardize the future development of lifesaving new tools addressing health challenges from cancer to HIV. One study found that NIH contributed to research associated with 99% of drugs approved over a decade. www.washingtonpost.com/education/in...

A research team has developed a simple, affordable #HPV test that delivers results in less than an hour outside of a specialized laboratory, which could be a breakthrough for improving access to cervical cancer screening for women in low-resource settings. www.ghtcoalition.org/blog/researc...

As GHTC heads to #WHS2025 this weekend, we're excited to connect with partners throughout the convening, including this important conversation on Tuesday on how to close the global health financing gap through innovative, sustainable, and inclusive solutions. 👇 www.id-alliance.org/event-detail...

Just a single new treatment for drug-resistant #TB could generate $740M in health care savings globally. That’s the power of #GlobalHealth R&D. #Innovate4Health www.ghtcoalition.org/resources-it...